Effect of White Potatoes on Glycemic Response, Satiety and Food Intake in Children

Sponsor
Ryerson University (Other)
Overall Status
Completed
CT.gov ID
NCT03307681
Collaborator
(none)
14
1
5
18
0.8

Study Details

Study Description

Brief Summary

The purpose of the present study is to explore the influence of cooking methods on post-prandial glycaemia and its impact on satiety in children.

Condition or Disease Intervention/Treatment Phase
  • Other: White bread
  • Other: Baked potato with skin
  • Other: Mashed potato served hot
  • Other: Fried French fries
  • Other: Meal skipping
N/A

Detailed Description

Each of the 5 study sessions will be at least 7 days apart. Either meal skipping, or one of three treatments of white potatoes (a) baked (with skin), (b) mashed, (c) fried French fries, or white bread, prepared on the day of testing, will be served to healthy children (9-14 years). Participants will consume the equivalent to 1 medium sized potato (~280 kcal) or an equivalent amount of calories from white bread. Glycemic response, insulin, incretin hormones (glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic peptide (GIP)), dipeptidyl peptidase 4 (DPP4), and cholecystokinin (CCK) will be measured for 2 h (0, 15, 30, 45, 60, 90 and 120 min) following meal consumption, as well as mood and subjective appetite. An ad libitum test meal will be provided at 120 min to assess food intake suppression.

Study Design

Study Type:
Interventional
Actual Enrollment :
14 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Effect of White Potatoes on Glycemic Response, Satiety and Food Intake in Children
Actual Study Start Date :
Dec 21, 2018
Actual Primary Completion Date :
Jun 21, 2020
Actual Study Completion Date :
Jun 21, 2020

Arms and Interventions

Arm Intervention/Treatment
Experimental: White bread

Matched for energy content and available carbohydrate content of potato treatments

Other: White bread
Toasted, with canola oil added to match for fat content of French fries (13.9 grams), as well as being matched for energy (280 kilocalories) and available carbohydrate content (33 grams) of potato treatments.

Experimental: Baked potato with skin

Baked russet potato

Other: Baked potato with skin
Baked russet potato with canola oil added once baked to match for fat content of French fries, and also matched for the salt content of white bread (280 milligrams).

Experimental: Mashed potato served hot

Mashed potatoes prepared from frozen, matched for available carbohydrate content of baked potato

Other: Mashed potato served hot
Mashed potatoes prepared from frozen, with canola oil added to match for fat content of French fries, as well as being matched for energy and available carbohydrate content of the baked potato.

Experimental: Fried French fries

Matched for available carbohydrate content of baked potato

Other: Fried French fries
Prepared from frozen, matched for energy and available carbohydrate content of baked potato and salt content of white bread.

Experimental: Meal skipping

No food given

Other: Meal skipping
No food given

Outcome Measures

Primary Outcome Measures

  1. Ad libitum food intake (lunch, at 120 minutes) [at 120 minutes post morning meal consumption]

    Food intake will be determined by weighing the meal before and after serving. The net weight of the test meal will be converted to calories

  2. Change from baseline glycemic response [15, 30, 45, 60, 90, and 120 minutes after meal consumption]

    Blood glucose (mmol/L). Blood glucose will be measured in whole blood using YSI 2300 STAT PLUS (YSI Incorporated, Yellow Springs, OH)

  3. Change from baseline insulin [15, 30, 45, 60, 90, and 120 minutes after meal consumption]

    Blood insulin (pmol/L). Insulin concentration in serum will be determined in duplicate via enzyme-linked immunosorbent assay kits (ELISA; Millipore, Billerica, Massachusetts).

Secondary Outcome Measures

  1. Change from baseline subjective appetite [15, 30, 45, 60, 90, and 120 minutes after meal consumption]

    Measured using visual analogue scale (mm). Each VAS is a 100 mm line where they will place a pencil mark to describe their feelings.

  2. Change from baseline mood [15, 30, 45, 60, 90, and 120 minutes after meal consumption]

    Measured using visual analogue scale (mm). Each VAS is a 100 mm line where they will place a pencil mark to describe their feelings.

  3. Change from baseline cholecystokinin (CCK) [15, 30, 45, 60, 90, and 120 minutes after meal consumption]

    Blood CCK (pmol/L). CCK concentration in serum will be determined in duplicate via enzyme-linked immunosorbent assay kits (ELISA; Millipore, Billerica, Massachusetts).

  4. Change from baseline dipeptidyl peptidase 4 (DPP4) [15, 30, 45, 60, 90, and 120 minutes after meal consumption]

    Blood DPP4 (ng/mL). DPP4 concentration in serum will be determined in duplicate via enzyme-linked immunosorbent assay kits (ELISA; Millipore, Billerica, Massachusetts).

  5. Change from baseline glucose-dependent insulinotropic peptide (GIP) [15, 30, 45, 60, 90, and 120 minutes after meal consumption]

    Blood GIP (pmol/L). GIP concentration in serum will be determined in duplicate via enzyme-linked immunosorbent assay kits (ELISA; Millipore, Billerica, Massachusetts).

  6. Change from baseline glucagon-like peptide-1 (GLP-1) [15, 30, 45, 60, 90, and 120 minutes after meal consumption]

    Blood GLP-1 (pmol/L). GLP-1 concentration in serum will be determined in duplicate via enzyme-linked immunosorbent assay kits (ELISA; Millipore, Billerica, Massachusetts).

Eligibility Criteria

Criteria

Ages Eligible for Study:
9 Years to 14 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • be between 9 and 14 years of age

  • be healthy, and have been born at term

  • be a native English speaker

  • not be taking any medications

  • not have allergies to potatoes, rice, or beans.

  • normal body weight (between the 5th and 85th BMI percentile for age and gender)

Exclusion Criteria:
  • anyone with food sensitivities or allergies to potatoes or potato-products,

  • smokers

  • diabetic or overweight/obese individuals.

Contacts and Locations

Locations

Site City State Country Postal Code
1 School of Nutrition, Ryerson University Toronto Ontario Canada M5B 2K3

Sponsors and Collaborators

  • Ryerson University

Investigators

  • Principal Investigator: Nick Bellissimo, PhD, Ryerson University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Nick Bellissimo, Associate Professor, Ryerson University
ClinicalTrials.gov Identifier:
NCT03307681
Other Study ID Numbers:
  • REB2017-330 II
First Posted:
Oct 12, 2017
Last Update Posted:
Sep 30, 2020
Last Verified:
Mar 1, 2020
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Nick Bellissimo, Associate Professor, Ryerson University

Study Results

No Results Posted as of Sep 30, 2020